| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |